ClinicalTrials.Veeva

Menu

Retinal Vascular Changes During Pregnancy

Vanderbilt University Medical Center logo

Vanderbilt University Medical Center

Status

Enrolling

Conditions

Pregnancy

Treatments

Diagnostic Test: Optical coherence tomography

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

The goal of this study is to better understand how the back part of the eye-called the retina and the choroid-changes during pregnancy. Specialized photos of the eye will be taken at three different timepoints: early in pregnancy (first or second trimester), late in pregnancy (third trimester), and after delivery. This imaging is non-invasive and does not require contact with the surface of the eye. The photos taken will allow assessment of specific parameters, like blood flow and the health of specialized cells that support vision. Understanding how the eyes change during pregnancy may help guide how retina specialists understanding of retinal disease during pregnancy and better inform pregnancy outcomes.

Full description

Pregnancy is a unique human condition marked by changes throughout the body, including changes in hormone levels, blood volume, blood pressure, and blood clot formation. These changes impact the eye as well, particularly the back part of the eye, called the retina and the choroid. Pre-existing conditions like diabetes and high blood pressure are known to affect the retina, but this impact may be increased by during pregnancy. In addition, new eye conditions may develop. The purpose of this study is to better understand how the retina and choroid changes during pregnancy.

Enrollment

90 estimated patients

Sex

Female

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Patient age 18 years and older
  2. Patient able to provide informed consent
  3. Pregnant at time of enrollment and in the 1st or 2nd trimester of pregnancy

Exclusion criteria

  1. Other ocular disease that prevents imaging (significant cataract or other media opacity)
  2. Unable to comply with imaging or follow-up through duration of study

Trial design

90 participants in 3 patient groups

Healthy Pregnant Patients
Description:
Health pregnancies
Treatment:
Diagnostic Test: Optical coherence tomography
Pregnant Patients with Pre-Existing Diabetes
Description:
Patients with pre-existing diabetes who are pregnant
Treatment:
Diagnostic Test: Optical coherence tomography
Pregnant Patients with Vascular Disease or Risk Factors for Vascular Disease
Description:
1. Multiple gestations 2. Preeclampsia or eclampsia 3. Gestational diabetes 4. Hypercoagulable state such as disseminated intravascular coagulation (DIC), thrombotic thrombocytopenic purpura (TTP), and hemolysis, elevated liver enzymes, and low platelets (HELLP) syndrome.
Treatment:
Diagnostic Test: Optical coherence tomography

Trial contacts and locations

1

Loading...

Central trial contact

Elise Timtim, MD; Saige Priddy

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems